Menarini, the leading Italian pharmaceutical group founded in 1886, has opened its regional headquarters in Dubai Science Park as part of its goal to expand its presence to the Middle East and Africa (MEA) region.

Specializing in pharmaceutical research and production, consumer healthcare, oncology, and diagnostics, the Group is basing its new regional office, Menarini Middle East and Africa, in Dubai as it acts as an ideal hub location to elevate patient health and wellbeing in the region and to form pivotal connections with key industry stakeholders.

Commenting on Menarini's new regional launch being perfectly aligned with the Dubai Industrial Strategy 2030, Dr. Ali Al Sayed, Director of Pharmaceutical Services Department at the Dubai Health Authority, said: "A defining objective of Dubai's 2030 strategy is to be a global hub for knowledge-based, sustainable and innovation focused businesses. As Menarini is a company with longstanding roots based in medical research, it will be a strong contributor to this visionary strategy.  Together, we share Dubai's overarching healthcare vision of positioning Dubai as the leading destination for healthcare knowledge, education and training."

Luca Lastrucci, Group General Manager at Menarini, commented: "We see this as a vital step in the right direction for Menarini and will continue to work side-by-side with the UAE government to raise healthcare standards and support the wellbeing of communities across the UAE and beyond."